Imodium and Pancreaze drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Pancreaze (pancrelipase (amylase;lipase;protease)). Common drug interactions include abnormal loss of weight among females and escherichia sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Pancreaze. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Pancreaze?

Pancreaze has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 847 Pancreaze users. Check the latest studies of Pancreaze.

On Jul, 24, 2026

12 people who take Imodium and Pancreaze together, and have interactions are studied.

Imodium and Pancreaze drug interactions.

What are the common drug interactions of Imodium and Pancreaze, by gender? *:

female:

Abnormal loss of weight
Asthenia (weakness)
Dyspepsia (indigestion)
Food poisoning (poison in food)
Hypotension (abnormally low blood pressure)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Sedation
Wound
Wound infection

male:

Escherichia sepsis (bacterial infection by escherichia coli)
Haematuria (presence of blood in urine)
Hypotension (abnormally low blood pressure)
Nail disorder (disease of nail)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Onychoclasis (breaking of the nails)
Rash
Retching (strong involuntary effort to vomit)
Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Imodium and Pancreaze, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Escherichia sepsis (bacterial infection by escherichia coli)
Haematuria (presence of blood in urine)
Haemoglobin decreased
Nephrolithiasis (calculi in the kidneys)
Thrombocytopenia (decrease of platelets in blood)

40-49:

n/a

50-59:

Hypotension (abnormally low blood pressure)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Sedation

60+:

Muscle spasms (muscle contraction)
Abnormal loss of weight
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Onychoclasis (breaking of the nails)
Rash
Retching (strong involuntary effort to vomit)
Syncope (loss of consciousness with an inability to maintain postural tone)
Vomiting
Blood urine present

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 3 people, 25.00%
Pain: 2 people, 16.67%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 16.67%
Thyroid Cancer: 1 person, 8.33%
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 1 person, 8.33%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 8.33%
Neoplasm Malignant (cancer tumour): 1 person, 8.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Cystic Fibrosis (disease of the secretary glands): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Pancreaze?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously